H-G, Dr. Linda Liau and her team at UCLA seem to contradict your comments. " There is unmet need for all tumor types. Question is are NWBO results real after all the bias built into the trial."
Device: Optune® Optune® is a commercial, portable, battery-operated device intended for continuous home use, which delivers TTFields at a frequency of 200kHz to the brain by means of insulated transducer arrays. The Optune® device produces electric forces intended to disrupt cancer cell division. https://clinicaltrials.gov/ct2/show/NCT04471844
The good news is that Dr. Linda Liau will "teach up to 1,000 SNO-EANO neurologists, neuro-oncologists, oncologists, neurosurgeons & other KOLs in the US & Europe about the $NWBO #DCVax-L Phase 3 trial results on 2/14/23 (Valentine’s Day):"
Per H-G comments, "Optune is approved, DCVax-L isn't, so until it gets approved if it does, Optune is the most efficacious choice." Many are praying for DCVax-L to be approved and with near zero side effects, perhaps the time is near that the helmet will take a back seat to DCVax-L, IMPO.